WLH Tumor Frequencies between cohort enrollment and 31-Dec Below the Women Lifestyle and Health tumor frequencies are tabulated according to:

Similar documents
WLH Tumor Frequencies between cohort enrollment and 31-Dec Below the Women Lifestyle and Health tumor frequencies are tabulated according to:

Cancer Association of South Africa (CANSA)

Cancer in Estonia 2014

ANNUAL CANCER REGISTRY REPORT-2005

APPENDIX ONE: ICD CODES

S2 File. Clinical Classifications Software (CCS). The CCS is a

82330 CALCIUM; IONIZED. ICD-10 Codes that Support Medical Necessity. ICD-10 Code. Description. A15.0 Tuberculosis of lung

155.2 Malignant neoplasm of liver not specified as primary or secondary. C22.9 Malignant neoplasm of liver, not specified as primary or secondary

2011 to 2015 New Cancer Incidence Truman Medical Center - Hospital Hill

Truman Medical Center-Hospital Hill Cancer Registry 2014 Statistical Summary Incidence

Annual Report. Cape Cod Hospital and Falmouth Hospital Regional Cancer Network Expert physicians. Quality hospitals. Superior care.

incidence rate x 100,000/year

Florida Cancer Data System STAT File Documentation Version 2019

All Discovered Death Outcome Detail (Form 124/120)

CEA (CARCINOEMBRYONIC ANTIGEN)

2016 Cancer Registry Annual Report

Cancer survival in Shanghai, China,

*

DATA REQUEST RESPONSE- XRT AND BRACHYTHERAPY

Globally Optimal Statistical Classification Models, I: Binary Class Variable, One Ordered Attribute

MALIGNANT NEOPLASMS OF THE BREAST MALIGNANT NEOPLASMS OF FEMALE GENITAL ORGANS

Cancer Incidence in Sweden 1998

John R. Marsh Cancer Center

Group B: Organ systems (digestive, respiratory, urinary, genital system, heart, glands and skin) green

BRAF Mutation Analysis

ICD-10 and Radiation Oncology

Clinical Coding for CRS Standards

Table E1. Standardized Mortality Ratios for Total and Specific Causes of Death Parameter Radiologists Psychiatrists No. of Deaths

Cancer survival in Hong Kong SAR, China,

END-SEMESTER EXAM 2018 ANATOMY, HISTOLOGY AND EMBRYOLOGY FACULTY OF MEDICINE, 2 ND SEMESTER

Cancer survival in Seoul, Republic of Korea,

Chapter II: Overview

American Cancer Society Estimated Cancer Deaths by Sex and Age (years), 2013

Comprehensive ICD-10-CM Casefinding Code List for Reportable Tumors for 2018 (Effective Dates: 10/1/2017-9/30/2018)

Model Policy. Coverage of Proton Therapy

2012 Cancer Report 2011 Registry Data

SCCA REFERENCE MANUAL ICD-10

Serum Iron Studies

Anatomical Considerations for Lab Practical II

Chapter 1 MAGNITUDE AND LEADING SITES OF CANCER

National Cancer Patient Experience Survey 2016 Technical Documentation July 2017

Contractor Information. LCD Information. Local Coverage Determination (LCD): Computerized Axial Tomography of the Chest/Thorax (L34416)

A Time- and Resource-Efficient Method for Annually Auditing All Reporting Hospitals in Your State: the Inpatient & Outpatient Hospital Discharge Files

CHAPTER 10 CANCER REPORT. Jeremy Chapman. and. Angela Webster

CLINICAL MEDICATION POLICY

Republican Research and Practical Center for Radiation Medicine and Human Ecology. Ilya Veyalkin Head of Laboratory of Epidemiology Gomel, Belarus

CLINICAL MEDICATION POLICY

Neoplasms/Lymphoma/Leukemia

Cancer Treatment Centers of America ATLANTA CANCER REGISTRY. Annual Report

Cancer in Utah: An Overview of Cancer Incidence and Mortality from

Cancer Program Report 2014

CODING PRIMARY SITE. Nadya Dimitrova

CANCER IN TASMANIA INCIDENCE AND MORTALITY 1999

Table S1. International classification of disease (ICD)-9 codes and descriptions of malignancy. types. Additional file 1

CLINICAL MEDICATION POLICY

Information Services Division NHS National Services Scotland

Research Article Cancer Incidence in Egypt: Results of the National Population-Based Cancer Registry Program

Appendix A: Definitions for Cancer Incidence Data

Introduction to ICD-O-3 coding rules

SEER Advanced Topic 2018 Presentation. EOD 2018 and SS2018 Jennifer Ruhl

Comprehensive cancer cover

HOSPITAL-BASED CANCER REGISTRY ANNUAL REPORT 2011

Carcinoembryonic Antigen

Peripheral Nerve Blocks

Cancer survival in Busan, Republic of Korea,

Comprehensive cancer cover

Cancer in Central and South America BOLIVIA

SHN-1 Human Digestive Panel Test results

Cancer in Colorado Incidence, Mortality, and Survival

CLIC Sargent Eligibility Criteria

Information Services Division NHS National Services Scotland

2014 CANCER CENTER ANNUAL REPORT

LCD for Interferon (L29202)

REPORTABLE CASES MISSISSIPPI For cases diagnosed 10/1/2015 and after

SKCC Protocol Review Committee New Study Application

Cancer Incidence in New Jersey Implementation of the Year 2000 Population Standard

Crosswalk File of ICD9 Diagnosis Codes to Risk Group Assignment 1-Apr-15

Checklist; Anus: Excisional Biopsy Anus: Excisional Biopsy 1/1/ Checklist; Anus: Resection Anus: Resection 1/1/2005

Subject Cancers in Firefighters and Fire Investigators

Interventions for non-metastatic squamous cell carcinoma of the skin: a systematic review and pooled analysis of observational studies

Contractor Information. LCD Information. Local Coverage Determination (LCD): CT of the Abdomen and Pelvis (L34415) Document Information

Cancer in Norway Cancer incidence, mortality, survival and prevalence in Norway

This lab activity is aligned with Visible Body s Human Anatomy Atlas app. Learn more at visiblebody.com/professors

Cancer in Norway Cancer incidence, mortality, survival and prevalence in Norway

Gamma Glutamyl Transferase

CANCER REGISTRY Annual Report

Genetic Testing for Cancer Susceptibility

Cancer in Norway Cancer incidence, mortality, survival and prevalence in Norway

Contractor Information. LCD Information. Local Coverage Determination (LCD): CT of the Abdomen and Pelvis (L34415) Document Information

Key Words. Cancer statistics Incidence Lifetime risk Multiple primaries Survival SEER

Outcomes Report: Accountability Measures and Quality Improvements

OVARIES URETER FALLOPIAN TUBES BLADDER UROGENITAL OPENINGS (BOTH SEXES) PENIS VAGINA UTERUS

Date Lab Pd. Lecture Notes (57)

CANCER IN TASMANIA INCIDENCE AND MORTALITY 1996

Colony Stimulating Factors: Neupogen (filgrastim), Neulasta (pegfilgrastim), Leukine (sargramostim), Granix (tbo-filgrastim)

Intensity Modulated Radiation Therapy (IMRT)

Cancer in New Mexico 2017

AMERICAN JOINT COMMITTEE ON CANCER AJCC CANCER STAGING

Estimated Minnesota Cancer Prevalence, January 1, MCSS Epidemiology Report 04:2. April 2004

Table of Contents. Last updated by CLO: 5/8/2013 1

Transcription:

WLH Tumor Frequencies between cohort enrollment and 31-Dec 2012 DESCRIPTION Below the Women Lifestyle and Health tumor frequencies are tabulated according to: Benign =171 (Cervix uteri) treated as not recorded =191 (non-melanoma skin cancer) treated as not recorded Tumors coded as benign (BEN=3) by the Swedish cancer register have been treated as not recorded Given the selections above only the 1st primary have been considered Only the 1st primary cases diagnosed after cohort enrollment and up to 31-Dec-211 are included in the tabulations below A 1st primary before enrollment censor the woman from further cancer events Information about emigration or death or other data sources have not been utilized Note: This presentation is intended for planning purposes only. Note: This is an update of the SAS program created earlier for data up to 31-Dec-2012 Pouran Almstedt, MEB - Karolinska Institutet 1/6 August 2014

WLH Tumor Frequencies between cohort enrollment and 31-Dec 2012 Malign 1st primary tumors after cohort enrollment up to 31Dec2012-3 digit codes =191 (non-melanoma skin cancer) not considered Percent of -3 digits Frequency Total codes Count Frequency 170 Breast 1849 42.428 190 Malignant melanoma of skin 282 6.471 162 Bronchus and trachea, and lung specified as primary 258 5.920 172 Corpus uteri 222 5.094 175 Ovary, Fallopian tube and broad ligament 213 4.888 193 Brain and other parts of nervous system 191 4.383 153 Large intestine, except rectum 188 4.314 154 Rectum 122 2.799 195 Other endocrine glands 108 2.478 199 Other and unspecified sites 113 2.593 171 Cervix uteri 83 1.905 200 Lymph sarcoma and reticulosarcoma 79 1.813 180 Kidney 77 1.767 181 Bladder and other urinary organs 65 1.492 157 Pancreas 57 1.308 194 Thyroid gland 50 1.147 203 Multiple myeloma (plasmocytoma) 40 0.918 151 Stomach 39 0.895 155 Biliary passages and of liver 39 0.895 204 Acute chronic and lymphoblastic leukaemia 32 0.734 205 Mycosis fungoides 31 0.711 197 Connective tissue 31 0.711 174 Uterus, unspecified 29 0.665 176 Other and unspecified female genital organs 26 0.597 141 Tongue 13 0.298 152 Small intestine, including duodenum 12 0.275 201 Hodgkin disease 12 0.275 144 Other parts of mouth 12 0.275 145 Oral mesopharynx 9 0.207 208 Polycytemia vera 9 0.207 209 Other, unspecified chronic myeloproliferative disease 9 0.207 150 Oesophagus 7 0.161 Pouran Almstedt, MEB - Karolinska Institutet 2/6 August 2014

Percent of -3 digits Frequency Total codes Count Frequency 202 Other forms of lymphoma (reticulosis) 7 0.161 207 Haematopoietic system 6 0.138 142 Malignant neoplasm of salivary gland 6 0.138 196 Malignant neoplasm of bone (including jaw bone) 4 0.092 160 Nose, nasal cavities, middle ear 4 0.092 206 Lymphatic system 3 0.069 143 Malignant neoplasm of floor of mouth 3 0.069 146 Malignant neoplasm of nasopharynx 3 0.069 140 Lip 2 0.046 158 Malignant neoplasm of peritoneum 2 0.046 161 Malignant neoplasm of larynx 1 0.023 164 Malignant neoplasm of mediastinum 1 0.023 173 Malignant neoplasm of other parts of uterus 1 0.023 ===== ====== 4358 100.0 Pouran Almstedt, MEB - Karolinska Institutet 3/6 August 2014

Malign 1st primary tumors after cohort enrollment up to 31Dec2012-4digit codes Benign =171 (Cervix uteri) or =191 (non-melanoma skin cancer) not considered Malignant neoplasm of breast (left) 1702 857 22.411 Malignant neoplasm of breast (right) 1701 826 21.600 Malignant neoplasm of bronchus and lung 1621 256 6.695 Malignant neoplasm of ovary 1750 198 5.178 Cerebral meninges/malignant neoplasm of brain 1930 163 4.263 Malignant melanoma of lower limb, including hip 1907 107 2.798 Malignant neoplasm of rectosigmoid junction 1540 107 2.798 Lymph nodes of head, face and neck/lymph node, unspecified- 1999 96 2.510 Secondary malignant neoplasm of liver Breast, unspecified 1708 91 2.380 Bålen, axill, ljumske, scapulareg, perineum 1905 79 2.066 Parathyroid gland 1951 68 1.778 Follicular/unspecified and other types of follicular NHL, 2001 73 1.909 unspecific T-cell/B-cell lymphoma. Sigmoid colon 1533 66 1.726 Overlapping lesion of breast 1707 66 1.726 Malignant neoplasm of bladder 1810 64 1.674 Malignant melanoma of upper limb, including shoulder 1906 54 1.412 Malignant neoplasm of colon (Caecum/Ascending colon) 1530 51 1.334 Malignant neoplasm of kidney (Unspecified) 1809 43 1.124 Malignant neoplasm of kidney, except renal pelvis 1800 28 0.732 Malignant melanoma of skin, unspecified 1909 26 0.680 Acute myeloid leukaemia 2050 21 0.549 Stomach, unspecified 1519 19 0.497 Chronic lymphocytic leukaemia 2041 23 0.601 Pituitary gland 1953 21 0.549 Liver cell carcinoma/intrahepatic bile duct carcinoma 1550 18 0.471 Malignant neoplasm of colon (Hepatic or Splenic flexure 1531 24 0.628 Colon, unspecified 1539 16 0.418 Appendix 1534 17 0.445 Anus, unspecified 1541 15 0.392 Spinal meninges/cerebral meninges 1931 16 0.418 Malignant neoplasm of colon (Descending colon) 1532 14 0.366 Pouran Almstedt, MEB - Karolinska Institutet 4/6 August 2014

Malign 1st primary tumors after cohort enrollment up to 31Dec2012-4digit codes Benign =171 (Cervix uteri) or =191 (non-melanoma skin cancer) not considered Central nervous system, unspecified/meninges, UNS 1939 12 0.314 Malignant neoplasm of gallbladder 1551 13 0.340 Abdomen/Ill-defined sites within the digestive system 1993 15 0.392 Cardia 1511 11 0.288 Malignant neoplasm of adrenal gland (Cortex/Medulla/Unspec. 1950 12 0.314 Vulva, unspecified 1760 12 0.314 Connective and soft tissue of lower limb, including hip 1973 10 0.262 Tonsil, unspecified (Nos, faucial, palatine 1450 9 0.235 Body of stomach, Pyloric antrum 1510 9 0.235 Overlapping lesion of female genital organs 1751 12 0.314 Malignant neoplasm of breast (unknown side) 1709 9 0.235 Connective and soft tissue of thorax/abdomen/pelvix 1977 10 0.262 Malignant melanoma of scalp and neck 1904 8 0.209 Chronic myeloid leukaemia 2051 8 0.209 Malignant neoplasm of vagina 1761 7 0.183 Malignant neoplasm of small intestine; Jejunum/Ileum 1527 6 0.157 Labium majus/labium minus 1767 6 0.157 Malignant neoplasm of renal pelvis 1801 6 0.157 Malignant neoplasm of base of tongue 1410 5 0.131 Small intestine; unspecified 1529 5 0.131 Extrahepatic bile duct 1552 6 0.157 Malignant melanoma of other and unspecified parts of face 1903 5 0.131 Malignant neoplasm of eye and adnexa, eyball/ciliary body 1920 7 0.183 Non-Hodgkin's lymphoma, unspecified type 2002 5 0.131 Malignant mast cell tumour, Peripheral T-cell lymphoma, 2021 6 0.157 Malignant- neoplasm without specification Acute lymphoblastic leukaemia 2040 8 0.209 Essential (haemorrhagic) thrombocythaemia 2079 5 0.131 Border of tongue 1417 4 0.105 Tongue, unspecified 1419 4 0.105 Middle third of oesophagus 1500 4 0.105 Oesophagus, unspecified 1509 3 0.078 Acute monocytic leukaemia 2060 3 0.078 External lower lip (nos, lipstick area, vermilion border) 1401 2 0.052 Pouran Almstedt, MEB - Karolinska Institutet 5/6 August 2014

Malign 1st primary tumors after cohort enrollment up to 31Dec 2012-4digit codes Benign =171 (Cervix uteri) or =191 (non-melanoma skin cancer) not considered Malignant neoplasm of parotid gland 1420 3 0.078 Major salivary gland (major) Nos 1429 2 0.052 Biliary tract, unspecified 1559 2 0.052 Pleura 1622 2 0.052 Malignant melanoma of ear and external auricular canal 1902 2 0.052 Endocrine pancreas 1955 2 0.052 Malignant neoplasm of bone (including jaw bone) - Lower limb, 1967 2 0.052 long bones Connective and soft tissue of trunk, unspecified 1971 2 0.052 Connective and soft tissue of upper limb,including shoulder 1972 2 0.052 Retroperitoneal rum 1974 2 0.052 Connective and soft tissue, unspecified 1979 4 0.105 Acute promyelocytic leukaemia, Acute myelomonocytic leuk. 2059 2 0.052 Submandibular gland 1426 1 0.026 Malignant neoplasm of small intestine, including duodenum 1520 1 0.026 Duodenum Nasal cavity Malignant neoplasm of nasal cavity 1600 1 0.026 Malignant neoplasm of Middle ear 1601 1 0.026 Etmoidalsinus (Ethmoid holes) 1607 1 0.026 Nose s sinus paranasales unspecified. 1609 1 0.026 Female genital organ, unspecified 1769 1 0.026 Urethra 1812 1 0.026 Overlapping malignant melanoma of skin 1908 1 0.026 Malignant neoplasm of eye 1923 1 0.026 Carotid body 1957 1 0.026 Mandible 1961 1 0.026 Malignant neoplasm of bone (including jaw bone) - Bones 1960 1 0.026 of the skull and face Connective and soft tissue of head, face and neck 1970 1 0.026 Malignant neoplasm of other and unspecified sites 1991 1 0.026 Malignant neoplasm of Pelvix 1994 1 0.026 Lymphosarcoma and reticulosarcoma 2003 1 0.026 Hairy-cell leukaemia 2024 1 0.026 Pouran Almstedt, MEB - Karolinska Institutet 6/6 August 2014

Malign 1st primary tumors after cohort enrollment up to 31Dec2012-4digit codes Benign =171 (Cervix uteri) or =191 (non-melanoma skin cancer) not considered Other lymphoid leukaemia 2049 1 0.026 Acute leukaemia of unspecified cell type 2070 1 0.026 ===== ===== Sum: 3824 100.0 Pouran Almstedt, MEB - Karolinska Institutet 7/6 August 2014